LIPO

Lipella Pharmaceuticals Inc

NASDAQ

Add Alert

LIPO

Lipella Pharmaceuticals Inc

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

oldstocks

03/04/24 5:52 PM

Post #19

Re: #17: @Monksdream - Roll the dice, gramps you can’t take it

You made me feel old, then i remembered my grandchildren
541,000 LIPO shares traded down 1.9%
Wow normally low volume
J A G X had a lot of volume too 380 mill
Pharmaceuticals are hot

Muhbruh

03/03/24 9:49 PM

Post #18

$LIPO Bio with nice bottom chart 6.6m float, 10 months of cash Insiders own 36% Warrants at $1.40 last offering was at $1.52 and has Upcoming catalyst pic.twitter.com/2j5I3G9MTE
— STOCKS Gambino (@StocksGambino) March 4, 2024

Monksdream PremiumMember

03/02/24 11:47 AM

Post #17

Re: #16: @oldstocks - This doesn’t trade many shares.

Roll the dice, gramps you can’t take it with you

oldstocks

03/02/24 11:45 AM

Post #16

Re: #15: @Monksdream - LIPO under $2

This doesn’t trade many shares.
Volume is coming

Monksdream PremiumMember

02/23/24 12:52 PM

Post #15

LIPO under $2

crudeoil24 PremiumMember

10/20/23 11:25 AM

Post #14

Re: #13: @crudeoil24 - Shares of Lipella Pharmaceuticals Inc. (LIPO) rocketed 52.2%

Heading to FDA phase II trial. Long ways to go before FDA phase III approval for marketplace.

crudeoil24 PremiumMember

10/20/23 11:21 AM

Post #13

Re: #11: @Awl416 - Lipella Pharmaceuticals Announces FDA Clearance of IND for

Shares of Lipella Pharmaceuticals Inc. (LIPO) rocketed 52.2% higher in very active tracing Friday, after the Pittsburgh-based biotechnology company's investigational new drug application for its oral lichen planus treatment was approved by the U.S. Food and Drug Administration. Trading volume in the stock, which was the best performer on the major U.S. exchanges, blasted higher to 30.7 million shares, compared with the full-day average of about 6,400 shares. The stock has soared 150% in the three days since it last closed below the $1 mark, and has run up 164% amid a six-day winning streak. as Lipella described, OLP is a chronic, inflammatory autoimmune oral muscosal disease. It is a "highly morbid" condition with malignant potential that affects between 1% and 4% of the world population. Lipella's stock has now gained 18.6% over the past three months, but was still 57% below its initial public offering price of $5.75; the company went public on Dec. 20.

-Tomi Kilgore

For more from MarketWatch: http://www.marketwatch.com/newsviewer

Monksdream PremiumMember

10/20/23 8:57 AM

Post #12

Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc

Awl416

10/20/23 8:07 AM

Post #11

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus

MiamiGent

03/16/23 3:20 PM

Post #10

That's it for me, folks!
Went much longer than usual but I have had a terrific day-following a bad day yesterday.
Hit on LIPO news today. Was positioned for the good pop. What a difference a day can make!
Have to drive across the mountain, now. Go do inventory at a shop open late. Then deliver there tomorrow.

LIPO Quote
AS OF 3/16/2023 3:16PM ET

$2.54
+$0.71 (+38.798%)

Volume
22,990,230
90 Day Avg. Vol.
564,085
Open
$2.77
Previous Close 03/15/2023
$1.83

https://stockcharts.com/h-sc/ui?s=LIPO

TheFinalCD PremiumMember

03/16/23 9:03 AM

Post #9

Re: #8: @81vette - Lipella Pharmaceuticals’ (NASDAQ:LIPO – Get Rating) quiet period

LIPO NEWS https://finance.yahoo.com/news/lipella-pharmaceuticals-successfully-completes-phase-123000776.html

Hemorrhagic cystitis is a medical condition that occurs when your urinary bladder lining becomes inflamed and bleeds. Your bladder is a muscular sac in your pelvis that stores urine before it's released from your body. Hemorrhagic means bleeding, and cystitis is inflammation of the bladder

81vette

02/06/23 2:56 PM

Post #8

Lipella Pharmaceuticals’ (NASDAQ:LIPO – Get Rating) quiet period will expire on Monday, January 30th. Lipella Pharmaceuticals had issued 1,217,391 shares in its IPO on December 20th. The total size of the offering was $6,999,998 based on an initial share price of $5.75. During Lipella Pharmaceuticals’ quiet period, insiders and underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

81vette

02/06/23 2:45 PM

Post #7

65,502 failure to deliver from 1-13 ,wow $300,000@$3.00pps ,insane margin call,shorts better cover now,at ask would put LIPO over $100pps right now ,set my sell at $150.00 just in case wink

Bullish

81vette

02/06/23 2:03 PM

Post #6

.05 spread,jumping .10-.50 today,no toxic debt or naked short on this newie,after market and pre-mkt tomorrow could gap LIPO multi$,gotta love low float newies wink

Bullish

81vette

02/06/23 12:51 PM

Post #5

35Xs ave vol,big pre mkt today 1st sign of life since ticker started,now gap filled,charting predictable,appears something coming and float locked up @zero/restricted borrow,436% fee